| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | AA | AB | AC | AD | AE | AF | AG | AH | AI | AJ | AK | AL | AM | AN | AO | AP | AQ | AR | AS | AT | AU | AV | AW | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Companies Ranked by Finance Value (Column G) | Ticker | 5-Yr Beta | Required Rate of Return (10-yr) | Actual Rate of Return (10-yr) | Risk Aversion = 2018 Price Return (worst year in past 10 for S&P 500) | Finance Value (Col E + Col F) | Market Cap ($B) | Dividend Yield | Free Cash Flow Yield (TTM) | 5-Yr Div Growth/yr | P/E (TTM) | EV/EBITDA (TTM) | Forward 1-yr PEG (Seeking Alpha) | Forward 3-5 year PEG (Morningstar) | BMW Method 16-yr Px CAGR | Recent Px Trend | BMW Method estimate of loss @ -2SD | Return on Tangible Capital Employed (lfy) | Return on Assets (TTM) | Return on Equity (TTM) | Return on Investment (TTM) | ROIC (TTM) | WACC (TTM) | Total Debt: EBITDA (mrq) | LT Debt: Equity (mrq) | TBV:Px (mrq) | Div:FCF (lfy) | S&P Bond Rating | S&P Stock Rating (Stars) | Px (50-d MA) | Shares BOT | Amount | Net Present Value @ 10-yr RRR Discount Rate (10-yr Holding Period + dividends) | Graham Number | Px (50-day MA): Graham Number | Px: Book | 7-Yr P/E | Px: Sales | Value Stock | Overpriced Stock | SCORE: Basic Quality Screen | Morningstar Rating | S&P Insider Activity | S&P Volatility | S&P Fair Value Rank | A-rated Company | VYM (High Dividend Yield) | VIG (Dividend Appreciation) | |
2 | S&P 100 Watch List | |||||||||||||||||||||||||||||||||||||||||||||||||
3 | Merck | MRK | 0.56 | 7.6% | 13.4% | 25.6% | 39.0% | $271 | 2.7% | 6.1% | 9.0% | 18 | 13 | 6.40 | 1.30 | 12.4% | up 1SD | 29% | 23.25% | 14.29% | 46.57% | 19.46% | 22.58% | 8.56% | 1.59 | 0.68 | 0.7% | 68% | A+ | B/M (5) | $94.92 | 53 | $5,030.76 | $3,718.44 | $50.16 | 177% | 6.1 | 44 | 4.6 | 4.0 | Over Valued (3) | unfavorable | low | 3 | yes | yes | ||||
4 | Union Pacific | UNP | 0.95 | 12.5% | 15.7% | 19.2% | 34.9% | $131 | 2.4% | 4.7% | 15.4% | 19 | 13 | 5.73 | 2.02 | 16.4% | down 1SD | 28% | 15.06% | 10.89% | 56.68% | 12.06% | 12.21% | 9.11% | 2.64 | 2.99 | 8.9% | 46% | A- | A-/M (3) | $202.16 | 25 | $5,054.00 | $2,898.54 | $70.06 | 309% | 11.1 | 24 | 5.5 | 4.0 | Under Valued (3) | favorable | low | 2 | yes | |||||
5 | Abbott Laboratories | ABT | 0.85 | 11.2% | 15.3% | 17.4% | 32.7% | $183 | 1.8% | 5.0% | 12.1% | 24 | 16 | neg EPS growth | 17.52 | 14.4% | down 1SD | 29% | 24.07% | 10.63% | 27.79% | 14.91% | 15.30% | 7.35% | 1.51 | 0.46 | 1.4% | 37% | AA- | B/L (4) | $100.88 | 50 | $5,044.00 | $2,143.80 | $47.39 | 219% | 5.2 | 57 | 4.2 | 4.0 | Under Valued (3) | unfavorable | low | 2 | yes | |||||
6 | Pfizer | PFE | 0.61 | 8.3% | 11.5% | 14.6% | 26.1% | $276 | 3.3% | 11.6% | 5.7% | 9 | 7 | neg EPS growth | NA | 11.0% | on trendline | 28% | 19.91% | 15.68% | 43.95% | 20.47% | 19.48% | 7.79% | 0.85 | 0.39 | 5.4% | 29% | A+ | B+/M (5) | $45.54 | 110 | $5,009.40 | $2,439.95 | $42.46 | 107% | 3.0 | 24 | 2.8 | yes | 4.0 | Fairly Valued (3) | neutral | low | 1 | yes | yes | |||
7 | Texas Instruments | TXN | 1.15 | 15.0% | 22.9% | -8.2% | 14.7% | $161 | 2.8% | 4.1% | 17.2% | 19 | 14 | neg EPS growth | 3.01 | 19.5% | on trendline | 40% | 45.88% | 35.44% | 63.68% | 39.70% | 66.41% | 8.99% | 0.67 | 0.55 | 6.3% | 62% | A+ | A+/M (3) | $163.45 | 31 | $5,066.95 | $3,354.65 | $56.28 | 294% | 11.1 | 33 | 8.2 | yes | 3.5 | Under Valued (2) | neutral | low | 3 | yes | yes | yes | ||
8 | Alphabet | GOOGL | 1.14 | 14.8% | 18.7% | -4.8% | 13.9% | $1,258 | 0.0% | 4.9% | 0.0% | 20 | 13 | 1.61 | 1.37 | 17.5% | down 1SD | 33% | 23.62% | 19.44% | 26.41% | 22.78% | 32.76% | 9.96% | 0.36 | 0.11 | 17.6% | 75% | AA+ | B+/M (4) | $96.69 | 52 | $5,027.88 | $1,186.92 | $48.76 | 217% | 5.0 | 41 | 4.6 | 4.0 | Under Valued (5) | unfavorable | low | 3 | no dividend | no dividend | no dividend | |||
9 | Home Depot | HD | 1.03 | 13.5% | 20.1% | -8.6% | 11.5% | $333 | 2.3% | 3.9% | 17.0% | 20 | 14 | 8.46 | 1.65 | 21.9% | down 1SD | 33% | 40.70% | 22.71% | -3656.69% | 39.44% | 34.57% | 8.37% | 1.80 | 38.30 | -1.8% | 50% | A | A+/M (4) | $289.73 | 17 | $4,925.41 | $5,915.46 | $21.77 | 1331% | 256.3 | 33 | 2.1 | 3.0 | Over Valued (2) | unfavorable | low | 4 | yes | yes | ||||
10 | Target | TGT | 0.84 | 11.1% | 13.1% | -3.0% | 10.1% | $73 | 2.7% | 0.5% | 10.2% | 22 | 11 | 0.38 | 3.31 | 12.5% | up 1SD | 42% | 17.13% | 7.39% | 30.51% | 15.83% | 10.68% | 9.11% | 2.78 | 1.73 | 14.7% | 30% | A | A/L (3) | $158.83 | 31 | $4,923.73 | $1,441.42 | $67.38 | 239% | 6.8 | 22 | 0.7 | 3.0 | Under Valued (4) | neutral | average | 1 | yes | yes | yes | |||
11 | Johnson & Johnson | JNJ | 0.56 | 7.6% | 12.8% | -3.7% | 9.1% | $462 | 2.6% | 4.5% | 6.0% | 25 | 16 | 5.51 | 3.82 | 11.2% | down 1SD | 19% | 25.34% | 10.74% | 35.37% | 14.55% | 16.57% | 6.47% | 1.06 | 0.43 | 0.2% | 56% | AAA | A-/M (3) | $168.84 | 30 | $5,065.20 | $2,737.18 | $68.49 | 241% | 6.2 | 32 | 4.9 | 4.0 | Over Valued (3) | unfavorable | low | 2 | yes | yes | yes | |||
12 | JPMorgan Chase | JPM | 1.11 | 14.5% | 16.0% | -10.5% | 5.5% | $396 | 3.0% | 38.3% | 14.4% | 12 | NA | 1.21 | NA | 13.1% | on trendline | 34% | 1.53% | 0.96% | 14.52% | 2.32% | NA | 6.33% | NA | 1.16 | 48.5% | 26% | A- | A-/L (3) | $120.20 | 42 | $5,048.40 | $490.44 | $152.30 | 75% | 1.6 | 13 | 3.3 | yes | 4.0 | Under Valued (4) | unfavorable | low | 1 | yes | yes | yes | ||
13 | Lockheed Martin | LMT | 0.70 | 9.4% | 21.3% | -18.4% | 2.9% | $126 | 2.5% | 7.1% | 9.0% | 22 | 15 | 20.79 | 3.55 | 16.9% | on trendline | 38% | 25.65% | 11.39% | 54.73% | 16.38% | 16.14% | 7.26% | 1.13 | 0.96 | -1.0% | 38% | A- | A/M (3) | $442.69 | 11 | $4,869.59 | $5,290.18 | $149.79 | 279% | 10.6 | 27 | 2.0 | 4.0 | Under Valued (3) | neutral | low | 1 | yes | yes | yes | |||
14 | Caterpillar | CAT | 1.02 | 13.3% | 13.9% | -18.2% | -4.3% | $123 | 2.0% | 3.0% | 8.3% | 17 | 13 | 2.64 | 1.57 | 12.5% | up 1SD | 40% | 10.97% | 10.58% | 41.76% | 14.13% | 10.42% | 7.89% | 2.84 | 2.34 | 6.0% | 49% | A | B/H (2) | $198.90 | 25 | $4,972.50 | $217.71 | $96.24 | 206% | 7.9 | 32 | 2.2 | 2.0 | Over Valued (2) | neutral | average | 3 | yes | yes | ||||
15 | United Parcel Service | UPS | 0.84 | 11.1% | 12.9% | -17.2% | -4.3% | $158 | 3.3% | 6.3% | 12.9% | 14 | 9 | neg EPS growth | 2.02 | 11.0% | on trendline | 27% | 21.66% | 16.03% | 71.90% | 24.81% | 21.73% | 8.41% | 1.41 | 1.41 | 6.9% | 32% | A | B+/M (3) | $169.01 | 30 | $5,070.30 | $1,275.98 | $75.05 | 225% | 9.3 | 28 | 1.6 | 4.0 | Under Valued (3) | neutral | low | 3 | yes | yes | yes | |||
16 | General Dynamics | GD | 0.83 | 11.0% | 16.9% | -23.1% | -6.2% | $69 | 2.0% | 7.3% | 8.7% | 21 | 15 | 1.37 | 1.94 | 12.5% | on trendline | 36% | 15.66% | 6.62% | 18.96% | 9.88% | 8.04% | 7.29% | 2.49 | 0.74 | -6.4% | 39% | A- | A+/M (3) | $236.97 | 21 | $4,976.37 | $1,235.38 | $129.84 | 177% | 4.0 | 23 | 1.8 | yes | 4.0 | Over Valued (3) | favorable | low | 3 | yes | yes | yes | ||
17 | Bristol Myers Squibb | BMY | 0.56 | 7.6% | 12.5% | -21.1% | -8.6% | $168 | 2.7% | 7.4% | 6.7% | 26 | 10 | 2.43 | NA | 11.3% | on trendline | 34% | 23.17% | 6.51% | 50.30% | 8.20% | 8.29% | 5.20% | 1.97 | 1.23 | -16.1% | 29% | A+ | B-/M (3) | $73.85 | 68 | $5,021.80 | $2,903.57 | $32.59 | 227% | 5.2 | 62 | 3.7 | 3.0 | Over Valued (2) | unfavorable | low | 2 | yes | yes | ||||
18 | Average | n = 15 | 0.85 | 11.2% | 15.8% | -4.0% | 11.8% | $279 | 2.4% | 7.6% | 10.2% | 19 | 13 | 5.14 | 3.59 | 14.3% | on trendline | 33% | 22.24% | 13.29% | -204.90% | 18.33% | 21.08% | 7.87% | 1.65 | 3.57 | 6.1% | 44% | A+ | A-/M (3) | $170.84 | $5,007.09 | $2,483.31 | $73.90 | 288% | 23.3 | 33 | 3.5 | 3/15 | 2/15 | 3.6 | Fairly Valued (3) | neutral | low | 2 | 9/15 | 12/15 | 12/15 | ||
19 | ||||||||||||||||||||||||||||||||||||||||||||||||||
20 | Benchmarks | |||||||||||||||||||||||||||||||||||||||||||||||||
21 | Vanguard Information Technology ETF | VGT | 1.17 | 15.2% | 18.7% | 1.7% | 20.4% | $46 | 0.9% | NA | 12.9% | 23 | NA | NA | NA | 17.2% | on trendline | 33% | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | $323.19 | 15 | $4,847.85 | $946.64 | NA | NA | 6.6 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |||
22 | Vanguard Health Care ETF | VHT | 0.78 | 10.4% | 14.8% | 3.4% | 18.2% | $20 | 1.3% | NA | 10.6% | 22 | NA | NA | NA | 13.7% | down 1SD | 24% | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | $235.46 | 21 | $4,944.66 | $1,924.57 | NA | NA | 4.3 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |||
23 | Vanguard Dividend Appreciation ETF | VIG | 0.87 | 11.5% | 12.4% | -2.6% | 9.8% | $75 | 1.9% | NA | 8.1% | 19 | NA | NA | NA | 11.5% | on trendline | 23% | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | $144.57 | 35 | $5,059.95 | $446.09 | NA | NA | 4.1 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |||
24 | Berkshire Hathaway | BRK-B | 0.87 | 11.5% | 13.7% | -4.1% | 9.6% | $698 | 0.0% | 2.8% | 0.0% | 61 | 70 | 8.35 | NA | 11.6% | on trendline | 25% | 4.14% | -0.06% | 3.35% | -0.06% | 0.01% | 8.31% | -98.10 | 0.26 | 50.5% | no dividend | AA | B/L (3) | $285.79 | 17.5 | $5,001.33 | -$209.38 | $155.61 | 184% | 1.5 | 15 | 2.8 | yes | 3.0 | Under Valued (4) | unfavorable | low | NR | no dividend | no dividend | no dividend | ||
25 | SPDR S&P 500 ETF | SPY | 1.00 | 13.1% | 13.1% | -4.2% | 8.9% | $367 | 1.6% | 2.0% | 4.7% | 18 | 16 | 3.95 | 1.61 | 10.2% | on trendline | 29% | NA | 3.23% | 21.35% | 6.46% | 10.20% | 8.55% | 9.65 | 1.60 | NA | NA | NA | NA | $378.27 | 13 | $4,917.51 | -$876.83 | $208.14 | 184% | 3.5 | 28 | 2.7 | NA | NA | NA | NA | NA | NA | NA | NA | |||
26 | Vanguard High Dividend Yield ETF | VYM | 0.86 | 11.4% | 12.0% | -7.2% | 4.8% | $61 | 3.0% | NA | 5.8% | 14 | NA | NA | NA | 10.6% | on trendline | 26% | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | $103.13 | 48 | $4,950.24 | $405.11 | NA | NA | 2.4 | NA | 2.1 | NA | NA | NA | NA | NA | NA | NA | NA | |||
27 | Vanguard Consumer Staples ETF | VDC | 0.64 | 8.6% | 10.8% | -6.9% | 3.9% | $8 | 2.3% | NA | 5.9% | 22 | NA | NA | NA | 10.4% | on trendline | 18% | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | $182.94 | 27 | $4,939.38 | $1,467.13 | NA | NA | 4.7 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |||
28 | Average | n = 7 | 0.88 | 11.7% | 13.6% | -2.8% | 10.8% | $182 | 1.6% | 2.4% | 6.9% | 26 | 43 | 6.15 | 1.61 | 12.2% | on trendline | 25% | 4.14% | 1.59% | 12.35% | 3.20% | 5.11% | 8.43% | -44.23 | 0.93 | 50.5% | NA | AA | B/L (3) | $236.19 | $4,951.56 | $586.19 | $181.88 | 184% | 3.9 | 22 | 2.5 | 1/1 | 0/1 | 3.0 | Under Valued (4) | unfavorable | low | ||||||
29 | ||||||||||||||||||||||||||||||||||||||||||||||||||
30 | Risk-free Rate | |||||||||||||||||||||||||||||||||||||||||||||||||
31 | Vanguard Intermed-Term Treasury | VFITX | 0.04 | - | 0.7% | 1.0% | 1.7% | $5 | 3.9% | -17.3% | 0.4% | down 2SD | 50% | AAA | NA | $9.89 | 496 | $5,004.64 | NM | |||||||||||||||||||||||||||||||
32 | ||||||||||||||||||||||||||||||||||||||||||||||||||
33 | Consumer Price Index | cpi | - | - | 2.7% | 1.5% | 4.2% | |||||||||||||||||||||||||||||||||||||||||||
34 | ||||||||||||||||||||||||||||||||||||||||||||||||||
35 | Updated 12/1/2022 | |||||||||||||||||||||||||||||||||||||||||||||||||
36 | ||||||||||||||||||||||||||||||||||||||||||||||||||
37 | Possibly Overpriced | |||||||||||||||||||||||||||||||||||||||||||||||||
38 | Advanced Micro Devices | AMD | 1.58 | 20.3% | 42.4% | 77.7% | 122.1% | $121 | no dividend | 3.1% | no dividend | 47 | 21 | 3.77 | 1.00 | 22.9% | on trendline | 83% | 32.21% | 6.15% | 12.78% | 7.17% | 0.38% | 9.24% | O.63 | 0.05 | 3.7% | no dividend | A- | B-/H (4) | $65.46 | 76 | $4,974.96 | $904.47 | $35.22 | 186% | 2.2 | 65 | 4.7 | 2.0 | Under Valued (4) | neutral | high | 2 | ||||||
39 | Eli Lilly | LLY | 0.66 | 8.9% | 25.2% | 47.2% | 72.4% | $342 | 1.1% | 1.6% | 12.9% | 55 | 41 | 2.88 | 2.19 | 22.4% | up 2SD | 43% | 21.15% | 12.52% | 80.80% | 15.90% | 20.78% | 3.50% | 1.98 | 1.58 | -0.3% | 52% | A+ | B+/M (3) | $345.15 | 14 | $4,832.10 | $10,729.44 | $40.92 | 843% | 34.5 | 94 | 11.3 | 3.5 | Over Valued (1) | favorable | low | 2 | yes | yes | ||||
40 | Adobe | ADBE | 1.27 | 16.5% | 25.5% | 24.1% | 49.6% | $151 | no dividend | 4.5% | no dividend | 33 | 34 | 1.93 | 1.65 | 22.8% | down 1SD | 56% | 45.97% | 18.11% | 44.39% | 25.65% | 19.07% | 7.65% | 0.68 | 0.32 | 0.0% | no dividend | A+ | B/M (4) | $304.66 | 16 | $4,874.56 | $3,048.01 | $88.63 | 344% | 10.8 | 55 | 9.2 | 3.5 | Under Valued (4) | unfavorable | average | 2 | ||||||
41 | Mastercard | MA | 1.22 | 15.8% | 22.5% | 24.9% | 47.4% | $317 | 0.6% | 3.0% | 17.4% | 35 | 25 | 2.07 | 1.30 | 24.2% | down 2SD | 30% | 40.07% | 26.64% | 148.94% | 40.48% | 43.32% | 8.84% | 1.08 | 2.29 | -1.3% | 20% | A+ | A+/M (4) | $312.67 | 16 | $5,002.72 | $4,951.87 | $38.58 | 810% | 53.1 | 56 | 15.9 | 3.5 | Under Valued (3) | unfavorable | low | 4 | yes | |||||
42 | UnitedHealth | UNH | 0.93 | 12.2% | 27.7% | 14.1% | 41.8% | $489 | 1.3% | 6.1% | 17.7% | 55 | 17 | 1.81 | 1.60 | 25.7% | on trendline | 46% | 19.11% | 8.40% | 26.59% | 14.75% | 10.45% | 7.95% | 1.47 | 0.65 | -4.0% | 27% | A+ | A+/M (5) | $525.66 | 10 | $5,256.60 | $11,218.54 | $191.43 | 275% | 6.7 | 43 | 1.6 | 3.5 | Over Valued (2) | favorable | low | 3 | yes | |||||
43 | Amazon | AMZN | 1.09 | 14.2% | 22.2% | 18.5% | 40.7% | $1,055 | no dividend | -2.8% | no dividend | 86 | 20 | NA | 5.19 | 26.0% | down 2SD | 36% | 6.49% | 2.70% | 14.44% | 4.42% | 3.24% | 6.89% | 2.33 | 0.93 | 11.9% | no dividend | AA | B/M (4) | $107.78 | 46 | $4,957.88 | $7,837.50 | $18.18 | 593% | 6.9 | 93 | 1.9 | 3.5 | Under Valued (4) | unfavorable | average | 1 | ||||||
44 | Microsoft | MSFT | 1.21 | 15.7% | 27.4% | 9.9% | 37.3% | $1,827 | 1.1% | 3.4% | 9.8% | 27 | 17 | 1.52 | 2.19 | 23.0% | on trendline | 47% | 29.78% | 20.73% | 42.10% | 26.04% | 28.50% | 8.80% | 0.61 | 0.35 | 5.2% | 37% | AAA | A/M (5) | $237.17 | 21 | $5,115.18 | $10,456.11 | $69.76 | 349% | 10.6 | 46 | 9.2 | 3.5 | Under Valued (4) | favorable | low | 2 | yes | |||||
45 | Nike | NKE | 1.06 | 13.8% | 17.1% | 20.0% | 37.1% | $147 | 1.3% | 2.1% | 11.1% | 30 | 20 | 1.33 | 3.46 | 18.1% | down 2SD | 28% | 17.46% | 15.33% | 37.08% | 18.87% | 25.84% | 7.23% | 1.70 | 0.80 | 8.9% | 41% | AA- | A-/L (2) | $95.54 | 52 | $4,968.08 | $2,432.43 | $28.31 | 337% | 10.5 | 39 | 3.6 | 3.5 | Under Valued (4) | favorable | low | 3 | yes | |||||
46 | NextEra Energy | NEE | 0.73 | 9.8% | 20.5% | 13.0% | 33.5% | $155 | 2.2% | -0.4% | 11.7% | 44 | 25 | 3.94 | 2.18 | 19.4% | on trendline | 33% | 5.41% | 1.95% | 12.27% | 2.43% | 3.56% | 3.19% | 4.63 | 1.68 | 20.1% | -9% | A- | A-/L (3) | $79.25 | 63 | $4,992.75 | $7,076.00 | $29.13 | 272% | 4.4 | 38 | 8.5 | 3.5 | Fairly Valued (3) | neutral | low | 1 | yes | yes | yes | |||
47 | Costco Wholesale | COST | 0.72 | 9.6% | 20.9% | 10.1% | 31.0% | $226 | 0.7% | 1.5% | 12.4% | 41 | 21 | 3.16 | 3.79 | 20.7% | up 1SD | 28% | 12.35% | 9.27% | 29.44% | 20.05% | 19.01% | 4.60% | 0.72 | 0.44 | 8.6% | 43% | A+ | A/L (3) | $493.34 | 10 | $4,933.40 | $7,889.51 | $117.41 | 419% | 11.4 | 57 | 1.1 | 3.5 | Over Valued (2) | unfavorable | low | 1 | yes | |||||
48 | Danaher | DHR | 0.85 | 11.2% | 21.1% | 9.5% | 30.6% | $183 | 0.4% | 3.6% | 12.0% | 29 | 20 | neg YoY growth | 3.17 | 19.5% | on trendline | 33% | 42.50% | 9.75% | 18.33% | 9.31% | 9.45% | 4.97% | 1.92 | 0.41 | -6.5% | 11% | A- | A-/M (3) | $259.78 | 19 | $4,935.82 | $4,981.31 | $112.72 | 231% | 4.3 | 63 | 6.3 | 4.0 | Over Valued (2) | neutral | low | 4 | ||||||
49 | Linde | LIN | 0.95 | 12.5% | 23.4% | 0.9% | 24.3% | $170 | 1.4% | 3.9% | 8.3% | 46 | 20 | 4.00 | 2.82 | 13.2% | up 1SD | 26% | 14.04% | 7.65% | 14.26% | 6.16% | 6.60% | 6.05% | 1.41 | 0.41 | 0.8% | 33% | A | A/M (4) | $297.61 | 17 | $5,059.37 | $608.73 | $113.71 | 260% | 4.5 | 48 | 5.2 | 4.0 | NA | unfavorable | low | 1 | yes | yes | yes | |||
50 | Apple | AAPL | 1.22 | 15.8% | 23.5% | -0.6% | 22.9% | $2,356 | 0.6% | 4.6% | 8.5% | 24 | 18 | 2.73 | 2.92 | 26.9% | on trendline | 38% | 36.20% | 25.89% | 160.90% | 46.31% | 33.18% | 10.85% | 1.06 | 2.37 | 2.1% | 13% | AA+ | A/L (4) | $146.14 | 34 | $4,968.76 | $7,193.79 | $20.91 | 701% | 46.5 | 40 | 6.1 | 3.5 | Over Valued (3) | unfavorable | low | 1 | ||||||
51 | Procter & Gamble | PG | 0.58 | 7.9% | 10.9% | 11.7% | 22.6% | $345 | 2.5% | 4.1% | 5.7% | 25 | 18 | 3.39 | 4.77 | 10.3% | on trendline | 23% | 39.83% | 12.32% | 32.66% | 17.52% | 13.42% | 5.92% | 1.43 | 0.75 | -5.5% | 65% | AA- | A-/L (4) | $133.78 | 37 | $4,949.86 | $1,975.68 | $49.98 | 273% | 8.0 | 33 | 4.6 | yes | 3.5 | Over Valued (2) | favorable | low | 2 | yes | yes | yes | ||
52 | Accenture PLC | ACN | 1.07 | 14.0% | 18.0% | -4.4% | 13.6% | $185 | 1.5% | 5.3% | 10.7% | 28 | 17 | 2.47 | 3.01 | 18.7% | down 1SD | 24% | 26.11% | 15.16% | 31.68% | 23.15% | 23.72% | 10.05% | 0.37 | 0.15 | 4.8% | 28% | AA- | A+/M (5) | $271.80 | 18 | $4,919.22 | $5,146.90 | $91.86 | 306% | 8.5 | 36 | 3.1 | 3.5 | Fairly Valued (2) | favorable | low | 3 | yes | |||||
53 | Honeywell International | HON | 0.97 | 12.7% | 16.5% | -6.1% | 10.4% | $148 | 1.9% | 3.1% | 6.7% | 28 | 18 | 4.01 | 2.10 | 14.8% | down 2SD | 32% | 17.95% | 8.04% | 30.73% | 13.14% | 10.39% | 9.17% | 2.31 | 0.96 | -1.7% | 51% | A | A-/M (3) | $190.72 | 27 | $4,959.63 | $2,512.72 | $65.53 | 281% | 8.4 | 29 | 4.3 | 4.0 | Under Valued (3) | neutral | low | NR | yes | yes | yes | |||
54 | Nvidia | NVDA | 1.73 | 22.2% | 50.3% | -41.5% | 8.8% | $345 | 0.1% | 1.2% | 2.7% | 44 | 35 | 1.47 | 3.83 | 36.9% | on trendline | 76% | 28.47% | 22.01% | 38.89% | 1.47% | 11.59% | 7.30% | 2.71 | 0.55 | 3.6% | 5% | A | B+/H (4) | $134.98 | 37 | $4,994.26 | $10,065.12 | $26.94 | 501% | 18.8 | 90 | 14.4 | 3.5 | Under Valued (4) | unfavorable | high | 1 | ||||||
55 | PepsiCo | PEP | 0.69 | 9.3% | 13.4% | -6.3% | 7.1% | $255 | 2.5% | 2.5% | 7.4% | 26 | 17 | 3.65 | 3.13 | 11.5% | on trendline | 19% | 22.63% | 10.40% | 51.13% | 15.42% | 12.23% | 6.88% | 2.35 | 2.07 | -6.5% | 83% | A+ | B+/L (5) | $173.90 | 29 | $5,043.10 | $1,853.97 | $46.52 | 373% | 13.4 | 34 | 3.1 | yes | 3.5 | Over Valued (2) | favorable | low | NR | yes | yes | yes | ||
56 | Walmart | WMT | 0.51 | 7.0% | 10.3% | -10.1% | 0.2% | $415 | 1.5% | 1.7% | 1.9% | 47 | 18 | 2.89 | 4.00 | 10.6% | on trendline | 22% | 13.82% | 6.80 | 19.54% | 13.82% | 7.49% | 4.25% | 8.57 | 0.91 | 14.1% | 56% | AA | B+/L (4) | $129.70 | 39 | $5,058.43 | $2,287.41 | $56.47 | 230% | 4.7 | 34 | 0.6 | 4.0 | Fairly Valued (3) | favorable | low | 2 | yes | yes | yes | |||
57 | Average | n = 19 | 1.00 | 13.1% | 23.1% | 11.2% | 34.4% | $486 | 1.3% | 2.7% | 9.8% | 39 | 22 | 2.77 | 2.86 | 20.4% | on trendline | 38% | 24.82% | 12.95% | 44.58% | 16.95% | 15.91% | 7.02% | 2.07 | 0.93 | 3.1% | 35% | A+ | $226.58 | $4,989.30 | $5,429.97 | $67.68 | 422% | 14.1 | 52 | 6.0 | 0/19 | 2/19 | 3.5 | Fairly Valued (3) | neutral | low | 2 | 7/19 | 7/19 | 12/19 |